Figure 4.Molecular docking between ginsenoside Rb1 and core targets protein. (A) The binding energy of molecular docking. (B) CCND1 and ginsenoside Rb1 molecular docking visualization.
Figure 4 — Exploring the anti-atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification | Aging
